Mitra Angkasa Sejahtera Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Mitra Angkasa Sejahtera Tbk. trades at Rp29 (market cap 134.41B, 984.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,500 (market cap 11.36T, 200K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 84.5× Mitra Angkasa Sejahtera Tbk.'s market cap, and Mitra Angkasa Sejahtera Tbk. is more actively traded (984.9K versus 200K). Which is the better fit depends on your goals.
| BAUT | TSPC | |
|---|---|---|
Market Cap | 134.41B | 11.36T |
Volume | 984.9K | 200K |
Lot | 9.85K | 2K |
Turnover | 28.4M | 500.06M |
Average Price | 28.84 | 2,500.28 |
Value | 28.4M | 500.06M |
Indicative Equilibrium Price | 29 | 2,500 |
Indicative Equilibrium Volume | 2.57K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitra Angkasa Sejahtera Tbk (“the Company”) is established based on Deed of Establishment No. 63 dated November 19, 2012 made by Doktorandus Wijanto Suwongso, S.H., Notary in Jakarta. The Company started its commercial operations in 2016.
Read more on BAUT →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →